Mary E. Rinella

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu et al. · Hepatology · 2023 · 2.5K citations · Full text

Evidence-based Medicine, Pathology, Fatty Liver Disease +16

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui et al. · Hepatology · 2023 · 2K citations · Full text

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance

Mary E. Rinella, Richard M. Green · Journal of Hepatology · 2003 · 437 citations

Obesity, Metabolic Syndrome, Insulin Resistance +10